The MoH also points out that pharmacy compounded products that are prepared on a large scale may be of importance for individual patients and that the possibility for large scale preparations should be facilitated based on strict conditions. In light hereof the MoH will further review recent European case law (C544/13 and C545/13 - the Abcur/Apoteket case) which provided for strict conditions for pharmacy preparations.

Dutch vision on medicinal products - how to ensure fast access for ...

Lexology (registration)-21 hours ago